A Phase 1/2 Study of Oncobax®-AK Administered in Combination With Immunotherapy To Patients With Advanced Solid Tumors
Latest Information Update: 28 Sep 2024
At a glance
- Drugs Oncobax AK (Primary)
- Indications Non-small cell lung cancer; Renal cell carcinoma; Solid tumours
- Focus Adverse reactions; First in man; Therapeutic Use
- Acronyms 6EVE1
- Sponsors EverImmune
- 26 May 2023 New trial record